Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lijun Zeng
Observed name:
Zeng, Lijun
Institutions:
First Affiliated Hospital of University of South China,
First Affiliated Hospital of Nanchang University,
University of South China
Observed institutions:
First Affiliated Hospital of University of South China,
First Affiliated Hospital of Nanchang University,
University of South China
ORCID:
0009-0009-1365-0567
Observed ORCID:
0009-0009-1365-0567
OpenAlex ID:
A5125454722
Exploring the impact of RPN1 on tumorigenesis and immune response in cancer
2025
·
Pengfei Luo
, Zhimin Li
, et al.
·
The FASEB Journal
·
4
Mitochondrial Quality Regulation Genes as Prognostic Markers in Hepatocellular Carcinoma: Tumor Microenvironment, Therapeutic Response, and Drug Sensitivity Analysis
2026
·
Binbin Li
, Lijun Zeng
, et al.
·
Drug Development Research
PDF
A Palmitoylation-Associated lncRNA Signature as a Prognostic Biomarker and Its Correlation With the Immune Microenvironment in Lung Adenocarcinoma
2026
·
Wenxin Ding
, Sixuan Wu
, et al.
·
Frontiers in Bioscience-Landmark
Single-cell hdWGCNA and experimental validation identify an innovative T-cell-associated prognostic model and immune microenvironment in lung adenocarcinoma with lymph node metastasis
2026
·
Sixuan Wu
, Lijun Zeng
, et al.
·
BMC Cancer
RTN4IP1 drives breast tumorigenesis: Molecular mechanisms linking elevated expression to enhanced proliferation, suppressed apoptosis, and therapeutic resistance
2026
·
Weijie He
, Yiling Jiang
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Show more works
View as search
Works count:
9
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type